The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-Analysis.
作者信息
Jiang Jianjun, Li Yanjiao, Dai Lifen, Wu Haiying, Hu Min
机构信息
The Research Center for Molecular Medicine, Kunming University, Kunming 650214, China.
Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650500, China.
出版信息
Int J Genomics. 2015;2015:597413. doi: 10.1155/2015/597413. Epub 2015 Mar 19.
Abstract
摘要
相似文献
1
The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-Analysis.表皮生长因子受体（EGFR）R521K多态性与癌症风险之间的关系：近期一项荟萃分析中数据需进一步阐明
Int J Genomics. 2015;2015:597413. doi: 10.1155/2015/597413. Epub 2015 Mar 19.
2
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.表皮生长因子受体（EGFR）R521K多态性与癌症风险关系的Meta分析
Int J Genomics. 2014;2014:312102. doi: 10.1155/2014/312102. Epub 2014 Oct 21.
3
The EGFR R521K polymorphism influences the risk to develop colorectal cancer.EGFR R521K 多态性影响结直肠癌的发病风险。
Cancer Biomark. 2010;8(2):61-5. doi: 10.3233/DMA-2011-0826.
4
5
Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.表皮生长因子受体多态性与皮肤毒性及头颈部鳞状细胞癌患者接受西妥昔单抗-多烯紫杉醇治疗结局的相关性。
Clin Cancer Res. 2010 Jan 1;16(1):304-10. doi: 10.1158/1078-0432.CCR-09-1928. Epub 2009 Dec 22.
6
Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms - 216 G>T, -191 C>A, (CA) n IVS1, and R521K.表皮生长因子受体在胃肿瘤中的表达及其与种系多态性-216 G>T、-191 C>A、(CA)n IVS1和R521K的关系。
Indian J Cancer. 2016 Jul-Sep;53(3):345-348. doi: 10.4103/0019-509X.200648.
7
EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.表皮生长因子（EGF）和表皮生长因子受体（EGFR）基因多态性可预测接受术后同步放化疗的局部晚期咽喉鳞状细胞癌患者的预后。
Onco Targets Ther. 2014 Nov 28;7:2197-204. doi: 10.2147/OTT.S70188. eCollection 2014.
8
Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk.需要澄清近期关于p53基因多态性与胃癌风险的荟萃分析中的数据。
Int J Cancer. 2010 May 15;126(10):2509. doi: 10.1002/ijc.24876.
9
Association between MMP2-1306C/T polymorphism and digestive cancer risk: need for clarification of data in a recent meta-analysis.基质金属蛋白酶2（MMP2）-1306C/T基因多态性与消化系统癌症风险之间的关联：近期一项荟萃分析中数据需进一步阐明
Arch Med Res. 2011 Nov;42(8):713-4; author reply 715-6. doi: 10.1016/j.arcmed.2011.11.007. Epub 2011 Dec 5.
10
Need for clarification of data in the recent meta-analysis about p53 codon 72 polymorphism and breast cancer risk.近期关于p53密码子72多态性与乳腺癌风险的荟萃分析中数据需要澄清。
Breast Cancer Res Treat. 2011 Aug;129(1):291-2. doi: 10.1007/s10549-011-1522-2. Epub 2011 Apr 20.
本文引用的文献
1
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.表皮生长因子受体（EGFR）R521K多态性与癌症风险关系的Meta分析
Int J Genomics. 2014;2014:312102. doi: 10.1155/2014/312102. Epub 2014 Oct 21.
2
HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.HER1 R497K 和 HER2 I655V 多态性与乳腺癌的发生有关。
Dis Markers. 2013;34(6):407-17. doi: 10.3233/DMA-130989.
3
Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer.表皮生长因子受体（EGFR）和人表皮生长因子受体2（HER2）基因多态性与甲状腺癌风险及临床特征的关联
Genet Test Mol Biomarkers. 2009 Dec;13(6):779-84. doi: 10.1089/gtmb.2009.0068.
4
A two-stage case-control study of EGFR polymorphisms and breast cancer risk.一项关于表皮生长因子受体（EGFR）基因多态性与乳腺癌风险的两阶段病例对照研究。
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):680-3. doi: 10.1158/1055-9965.EPI-08-0961. Epub 2009 Feb 3.
Zotero 插件